CSS LLC’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-20,000
| Closed | -$134K | – | 1128 |
|
|
2025
Q4 | $134K | Sell |
20,000
-10,000
| -33% | -$75.4K | 0.01% | 815 |
|
|
2025
Q3 | $260K | Buy |
30,000
+10,000
| +50% | +$77.8K | 0.01% | 707 |
|
|
2025
Q2 | $126K | Hold |
20,000
| – | – | 0.01% | 812 |
|
|
2025
Q1 | $128K | Sell |
20,000
-156,100
| -89% | -$1.29M | 0.01% | 764 |
|
|
2024
Q4 | $1.42M | Hold |
176,100
| – | – | 0.06% | 251 |
|
|
2024
Q3 | $2.22M | Buy |
176,100
+2,500
| +1% | +$32.3K | 0.1% | 147 |
|
|
2024
Q2 | $2.2M | Sell |
173,600
-24,000
| -12% | -$241K | 0.11% | 130 |
|
|
2024
Q1 | $945K | Sell |
197,600
-35,000
| -15% | -$162K | 0.05% | 286 |
|
|
2023
Q4 | $1.12M | Buy |
232,600
+27,500
| +13% | +$168K | 0.06% | 220 |
|
|
2023
Q3 | $1.48M | Sell |
205,100
-20,000
| -9% | -$160K | 0.1% | 174 |
|
|
2023
Q2 | $1.67M | Buy |
225,100
+150,100
| +200% | +$1.18M | 0.1% | 154 |
|
|
2023
Q1 | $520K | Sell |
75,000
-15,600
| -17% | -$144K | 0.03% | 308 |
|
|
2022
Q4 | $931K | Buy |
90,600
+48,400
| +115% | +$854K | 0.05% | 275 |
|
|
2022
Q3 | $767K | Sell |
42,200
-36,400
| -46% | -$1.58M | 0.04% | 410 |
|
|
2022
Q2 | $4.04M | Buy |
78,600
+73,400
| +1,412% | +$3.8M | 0.16% | 139 |
|
|
2022
Q1 | $382K | Sell |
5,200
-108,200
| -95% | -$9.65M | 0.01% | 682 |
|
|
2021
Q4 | $16.2M | Sell |
113,400
-5,000
| -4% | -$859K | 0.58% | 32 |
|
|
2021
Q3 | $24.5M | Sell |
118,400
-5,100
| -4% | -$1.12M | 1.04% | 12 |
|
|
2021
Q2 | $26.2M | Buy |
123,500
+3,300
| +3% | +$605K | 1.09% | 13 |
|
|
2021
Q1 | $21.8M | Sell |
120,200
-30,400
| -20% | -$6.06M | 0.9% | 17 |
|
|
2020
Q4 | $16.8M | Buy |
150,600
+16,100
| +12% | +$1.71M | 0.64% | 29 |
|
|
2020
Q3 | $14.6M | Buy |
134,500
+44,800
| +50% | +$5.46M | 0.69% | 20 |
|
|
2020
Q2 | $7.48M | Buy |
+89,700
| New | +$3.43M | 0.42% | 53 |
|
|
2019
Q2 | – | Sell |
-4,000
| Closed | -$45K | – | 856 |
|
|
2019
Q1 | $45K | Buy |
4,000
+2,000
| +100% | +$63.1K | ﹤0.01% | 499 |
|
|
2018
Q4 | $73K | Buy |
2,000
+500
| +33% | +$19.4K | ﹤0.01% | 474 |
|
|
2018
Q3 | $57K | Buy |
+1,500
| New | +$42.2K | ﹤0.01% | 505 |
|
|
2017
Q1 | – | Sell |
-530
| Closed | -$13K | – | 699 |
|
|
2016
Q4 | $13K | Hold |
530
| – | – | ﹤0.01% | 678 |
|
|
2016
Q3 | $22K | Hold |
530
| – | – | ﹤0.01% | 694 |
|
|
2016
Q2 | $77K | Buy |
+530
| New | +$60.7K | 0.01% | 642 |
|
Other funds holding NVAX
SCM
VPM
VCM
S
CSS LLC's NVAX Position: Q3 2024 in Review
CSS LLC sold out of Novavax (NVAX) in Q3 2024, closing a stake of 6,000 shares — an estimated $77.5K sold.
CSS LLC first reported a position in NVAX in Q2 2020 and held it in 9 quarters. The position peaked at $1.62M in Q4 2020. 238 funds tracked by Wall St. Rank hold NVAX as of Q3 2024.
- CSS LLC reported no remaining Novavax position as of Q3 2024 after selling out during the quarter.
- CSS LLC sold 6,000 Novavax shares in Q3 2024, an estimated $77.5K.
- CSS LLC first reported a position in Novavax in Q2 2020 and held it in 9 quarters.
- CSS LLC's Novavax position peaked at $1.62M in Q4 2020.
- 238 funds tracked by Wall St. Rank held Novavax as of Q3 2024.
Based on CSS LLC's 13F filing for Q3 2024, filed 14 Nov 2024.